8.31
price up icon30.87%   1.96
after-market アフターアワーズ: 8.54 0.23 +2.77%
loading
前日終値:
$6.35
開ける:
$6.35
24時間の取引高:
3.84M
Relative Volume:
5.08
時価総額:
$570.35M
収益:
-
当期純損益:
$-96.66M
株価収益率:
-3.8651
EPS:
-2.15
ネットキャッシュフロー:
$-83.73M
1週間 パフォーマンス:
+52.20%
1か月 パフォーマンス:
+54.75%
6か月 パフォーマンス:
+95.07%
1年 パフォーマンス:
-29.75%
1日の値動き範囲:
Value
$6.35
$8.44
1週間の範囲:
Value
$5.36
$8.44
52週間の値動き範囲:
Value
$2.86
$13.93

Olema Pharmaceuticals Inc Stock (OLMA) Company Profile

Name
名前
Olema Pharmaceuticals Inc
Name
セクター
Healthcare (1149)
Name
電話
(415) 651-3316
Name
住所
780 BRANNAN STREET, SAN FRANCISCO
Name
職員
117
Name
Twitter
Name
次回の収益日
2025-03-18
Name
最新のSEC提出書
Name
OLMA's Discussions on Twitter

OLMA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
OLMA
Olema Pharmaceuticals Inc
8.31 435.83M 0 -96.66M -83.73M -2.15
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.12 101.77B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.38 60.12B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
452.00 59.45B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
750.78 44.90B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
341.80 35.07B 3.81B -644.79M -669.77M -6.24

Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-08-12 繰り返されました Citigroup Buy
2024-04-02 開始されました Goldman Buy
2024-01-30 開始されました Citigroup Buy
2023-07-21 開始されました Oppenheimer Outperform
2023-05-05 開始されました CapitalOne Overweight
2023-02-22 開始されました Credit Suisse Outperform
2022-07-06 再開されました Canaccord Genuity Buy
2022-06-09 アップグレード H.C. Wainwright Neutral → Buy
2022-02-28 開始されました H.C. Wainwright Neutral
2021-12-07 再開されました Cowen Outperform
2020-12-14 開始されました Canaccord Genuity Buy
2020-12-14 開始されました Cowen Outperform
2020-12-14 開始されました JP Morgan Overweight
2020-12-14 開始されました Jefferies Buy
すべてを表示

Olema Pharmaceuticals Inc (OLMA) 最新ニュース

pulisher
02:54 AM

What data driven models say about Olema Pharmaceuticals Inc.’s futureJuly 2025 Price Swings & Advanced Technical Analysis Signals - Newser

02:54 AM
pulisher
02:28 AM

What MACD and RSI say about Olema Pharmaceuticals Inc.2025 Key Highlights & Detailed Earnings Play Strategies - Newser

02:28 AM
pulisher
05:02 AM

Signal strength of Olema Pharmaceuticals Inc. stock in tech scannersJuly 2025 Outlook & Free Technical Pattern Based Buy Signals - Newser

05:02 AM
pulisher
03:13 AM

Will Olema Pharmaceuticals Inc. stock recover after earningsJuly 2025 Earnings & AI Enhanced Trading Alerts - خودرو بانک

03:13 AM
pulisher
02:22 AM

Can Olema Pharmaceuticals Inc. maintain its current growth rate2025 Volume Leaders & Technical Buy Zone Confirmation - خودرو بانک

02:22 AM
pulisher
02:22 AM

Is Olema Pharmaceuticals Inc. a play on infrastructure spendingJuly 2025 Chart Watch & Fast Gaining Stock Reports - خودرو بانک

02:22 AM
pulisher
Sep 05, 2025

Oppenheimer Reaffirms "Outperform" Rating for Olema Pharmaceuticals (NASDAQ:OLMA) - MarketBeat

Sep 05, 2025
pulisher
Sep 05, 2025

Olema Pharmaceuticals shares surge 20.49% intraday after announcing clinical trial collaboration with Pfizer for breast cancer treatment. - AInvest

Sep 05, 2025
pulisher
Sep 05, 2025

How high can Olema Pharmaceuticals Inc. stock goJuly 2025 Setups & AI Enhanced Trading Signals - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Olema Pharmaceuticals, Inc. $OLMA Shares Sold by BVF Inc. IL - MarketBeat

Sep 05, 2025
pulisher
Sep 05, 2025

Olema Pharmaceuticals, Inc. $OLMA Shares Sold by Bain Capital Life Sciences Investors LLC - MarketBeat

Sep 05, 2025
pulisher
Sep 05, 2025

Regression analysis insights on Olema Pharmaceuticals Inc. performanceJuly 2025 Update & Daily Entry Point Alerts - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Paradigm Biocapital Advisors LP Reduces Holdings in Olema Pharmaceuticals, Inc. $OLMA - MarketBeat

Sep 05, 2025
pulisher
Sep 05, 2025

Multi factor analysis applied to Olema Pharmaceuticals Inc.Earnings Growth Summary & Free Expert Approved Momentum Trade Ideas - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Olema Pharmaceuticals Inc. recovery potential after sell offQuarterly Market Review & Long Hold Capital Preservation Plans - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Olema Pharmaceuticals Inc. stock outlook for YEAR2025 Macro Impact & Free Accurate Trade Setup Notifications - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Is Olema Pharmaceuticals Inc. trending in predictive chart modelsTrade Risk Assessment & Long-Term Safe Return Strategies - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Is Olema Pharmaceuticals Inc. stock poised for growthJuly 2025 Fed Impact & Smart Money Movement Tracker - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

How to read the order book for Olema Pharmaceuticals Inc.Portfolio Value Summary & AI Based Buy/Sell Signal Reports - Newser

Sep 05, 2025
pulisher
Sep 04, 2025

Is Olema Pharmaceuticals Inc. a top pick in the sectorStock Surge & Safe Capital Growth Trade Ideas - خودرو بانک

Sep 04, 2025
pulisher
Sep 04, 2025

Published on: 2025-09-05 21:58:24 - خودرو بانک

Sep 04, 2025
pulisher
Sep 04, 2025

Why Olema Pharmaceuticals Inc. is moving todayJuly 2025 Summary & Scalable Portfolio Growth Methods - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Does Olema Pharmaceuticals Inc. outperform in volatile markets2025 Fundamental Recap & Smart Allocation Stock Reports - خودرو بانک

Sep 04, 2025
pulisher
Sep 04, 2025

Pfizer collaboration with Olema may spark future bidding waranalyst - MSN

Sep 04, 2025
pulisher
Sep 04, 2025

Olema Pharmaceuticals Inc. stock trendline breakdown2025 Analyst Calls & Long-Term Safe Investment Plans - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Will Olema Pharmaceuticals Inc. stock hit new highs in YEARJuly 2025 Price Swings & Daily Price Action Insights - خودرو بانک

Sep 04, 2025
pulisher
Sep 03, 2025

Olema Oncology’s Strategic Use of Equity Incentives to Fuel R&D and Talent Growth - AInvest

Sep 03, 2025
pulisher
Sep 03, 2025

Oppenheimer maintains Olema stock rating, sees Pfizer deal as strategic By Investing.com - Investing.com Canada

Sep 03, 2025
pulisher
Sep 03, 2025

Olema Pharmaceuticals Grants Stock Options to New Employees Under 2022 Inducement Plan - Quiver Quantitative

Sep 03, 2025
pulisher
Sep 03, 2025

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Sep 03, 2025
pulisher
Sep 03, 2025

124,000 Shares: Olema Oncology Grants New Employee Stock Options with 4-Year Vesting Terms - Stock Titan

Sep 03, 2025
pulisher
Sep 03, 2025

Wellington Management Group LLP Lowers Holdings in Olema Pharmaceuticals, Inc. $OLMA - MarketBeat

Sep 03, 2025
pulisher
Sep 03, 2025

Pfizer's partnership with Olema may spark a bidding war for the biotech firm. - AInvest

Sep 03, 2025
pulisher
Sep 03, 2025

Pfizer (PFE) Partners With Olema For New Metastatic Breast Cancer Study - simplywall.st

Sep 03, 2025
pulisher
Sep 03, 2025

Is Olema Pharmaceuticals Inc. likely to announce a buybackJuly 2025 Intraday Action & Weekly Sector Rotation Insights - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

When is the best time to exit Olema Pharmaceuticals Inc.Gap Down & High Conviction Buy Zone Picks - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

H.C. Wainwright reiterates Buy rating on Olema Pharmaceuticals stock By Investing.com - Investing.com South Africa

Sep 03, 2025
pulisher
Sep 03, 2025

H.C. Wainwright reiterates Buy rating on Olema Pharmaceuticals stock - Investing.com

Sep 03, 2025
pulisher
Sep 03, 2025

How does Olema Pharmaceuticals Inc. correlate with NasdaqTrade Volume Summary & Safe Capital Allocation Plans - خودرو بانک

Sep 03, 2025
pulisher
Sep 03, 2025

What technical models suggest about Olema Pharmaceuticals Inc.’s comeback2025 Top Gainers & Verified Short-Term Trading Plans - Newser

Sep 03, 2025

Olema Pharmaceuticals Inc (OLMA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
大文字化:     |  ボリューム (24 時間):